Sophonix is a biotechnology company.
Sophonix focuses on the development, production and sales of in vitro diagnostic instruments and reagents, providing accurate POCT solutions.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 23, 2020 | Series B | ¥100M | 3 | Zero2IPO Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Zero2IPO Capital | Yes | Series B |
ETP Fund | — | Series B |
Anlongmed Fund | — | Series B |